ONCY Oncolytics Biotech Inc. - Common Shares
$0,79
Precio · May 20, 2026
Fundamentales a fecha de May 14, 2026
Rango 52S
$0–$2
39% of range
Calificación del Analista
BUY
8 analysts
Precio Objetivo
$5
+545% upside
P/E (TTM)
-2.9
ROE
11480.6%
Margen de Beneficio Neto
—
ONCY Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$0.79
Capitalización Bursátil
$94M
P/E (TTM)
-2.9
BPA (TTM)
$-0.30
Ingresos (TTM)
—
Rendimiento div.
—
ROE
11480.6%
Deuda/Capital
—
Rango 52S
$0 – $2
ONCY Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
—
BPA
$-0.30
2024-12-31
→
2025-12-31
Flujo de caja libre
$-20M
2025-12-31
→
2025-12-31
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
ONCY
Mediana de Pares
P/E (TTM)
-2.9
—
P/B (P/C)
-24.7
3.5
Price / FCF (Precio / FCF)
-4.7
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
ONCY
Mediana de Pares
ROA
-273.9%
-40.8%
ROE
11480.6%
-46.2%
ROIC
758.2%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
ONCY
Mediana de Pares
Current Ratio (Ratio corriente)
1.1
6.9
Quick Ratio (Ratio Rápido)
0.9
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
ONCY
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
ONCY
Mediana de Pares
ONCY Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
8 analistas
- Compra fuerte 1 12,5%
- Compra 5 62,5%
- Mantener 2 25,0%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
6 analistas · 2026-05-19
Mediana
$4.25
Media
$5.07
← Por Debajo de Todos los Objetivos
$0.79
Mín
$2.94
Máx
$9.89
Objetivo mediano
$4.25
+440,2%
Objetivo medio
$5.07
+544,7%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.01%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de septiembre de 2025 | $-0.14 | $-0.10 | -0.04% |
| 30 de junio de 2025 | $-0.07 | $-0.11 | 0.04% |
| 31 de marzo de 2025 | $-0.08 | $-0.10 | 0.02% |
| 31 de diciembre de 2024 | $-0.10 | $-0.12 | 0.02% |
Comparación con pares Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| ONCY | $94M | -2.9 | — | — | 11480.6% | — |
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | — |
| ACOG | $141M | -5.5 | — | -202.2% | -43.8% | — |
| ENGN | — | — | — | — | — | — |
| EDSA | $18M | — | — | — | -51.3% | — |
| XENE | $3.59B | -10.3 | — | -4612.1% | -56.9% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 14
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| R&D Expense | $13M | $15M | |
| SG&A Expense | $15M | $10M | |
| Operating Expenses | $29M | $26M | |
| Operating Income | $-29M | $-26M | |
| Interest Income | $386.0K | $975.0K | |
| Other Non-op | $45.0K | $3M | |
| Pretax Income | $-29M | $-23M | |
| Income Tax | $79.0K | $95.0K | |
| Net Income | $-29M | $-23M | |
| EPS (Basic) | $-0.30 | $-0.30 | |
| EPS (Diluted) | $-0.30 | $-0.30 | |
| Shares (Basic) | 95,857,147 | 76,482,914 | |
| Shares (Diluted) | 95,857,147 | 76,482,914 | |
| EBITDA | $-29M | · |
Balance general 19
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $5M | $11M | |
| Prepaid Expense | $1M | $1M | |
| Current Assets | $7M | $12M | |
| PP&E (Net) | $228.0K | $286.0K | |
| PP&E (Gross) | $754.0K | $725.0K | |
| Accum. Depreciation | $526.0K | $439.0K | |
| Total Assets | $8M | $13M | |
| Accounts Payable | $4M | $756.0K | |
| Accrued Liabilities | $2M | $3M | |
| Current Liabilities | $6M | $5M | |
| Capital Leases | $370.0K | $561.0K | |
| Total Liabilities | $11M | $10M | |
| Common Stock | $0 | $0 | |
| Paid-in Capital | $419M | $398M | |
| Retained Earnings | $-429M | $-401M | |
| AOCI | $6M | $6M | |
| Stockholders' Equity | $-4M | $3M | |
| Liabilities + Equity | $8M | $13M | |
| Shares Outstanding | 108,021,271 | 80,020,131 |
Flujo de Efectivo 9
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Stock-based Comp | $3M | $2M | |
| Deferred Tax | $0 | $0 | |
| Operating Cash Flow | $-20M | $-20M | |
| CapEx | $6.0K | $174.0K | |
| Investing Cash Flow | $-6.0K | $-174.0K | |
| Financing Cash Flow | $14M | $5M | |
| Net Change in Cash | $-6M | $-15M | |
| Taxes Paid | $67.0K | $134.0K | |
| Free Cash Flow | $-20M | · |
Rentabilidad 3
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| ROA | -273.9% | · | |
| ROE | 11480.6% | · | |
| ROIC | 758.2% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 1.1 | · | |
| Quick Ratio | 0.9 | · |
Valoración (TTM) 7
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Net Income TTM | $-29M | · | |
| Market Cap | $94M | · | |
| P/E | -2.9 | · | |
| P/B | -24.7 | · | |
| P / Cash Flow | -4.7 | · | |
| P / FCF | -4.7 | · | |
| Earnings Yield | -34.5% | · |
Estado de resultados 12
| Métrica | Tendencia | Q1 2026 | Q4 2025 |
|---|---|---|---|
| R&D Expense | $5M | · | |
| SG&A Expense | $5M | · | |
| Operating Expenses | $9M | · | |
| Operating Income | $-9M | · | |
| Interest Income | $44.0K | · | |
| Other Non-op | $38.0K | · | |
| Net Income | $-9M | · | |
| EPS (Basic) | $-0.08 | · | |
| EPS (Diluted) | $-0.08 | · | |
| Shares (Basic) | 112,292,579 | · | |
| Shares (Diluted) | 112,292,579 | · | |
| EBITDA | $-9M | · |
Balance general 19
| Métrica | Tendencia | Q1 2026 | Q4 2025 |
|---|---|---|---|
| Cash & Equivalents | $5M | $5M | |
| Prepaid Expense | $1M | $1M | |
| Current Assets | $7M | $7M | |
| PP&E (Net) | $218.0K | $228.0K | |
| PP&E (Gross) | · | $754.0K | |
| Accum. Depreciation | · | $526.0K | |
| Total Assets | $8M | $8M | |
| Accounts Payable | $3M | $4M | |
| Accrued Liabilities | $3M | $2M | |
| Current Liabilities | $5M | $6M | |
| Capital Leases | $342.0K | $370.0K | |
| Total Liabilities | $13M | $11M | |
| Common Stock | $0 | $0 | |
| Paid-in Capital | $427M | $419M | |
| Retained Earnings | $-439M | $-429M | |
| AOCI | $6M | $6M | |
| Stockholders' Equity | $-5M | $-4M | |
| Liabilities + Equity | $8M | $8M | |
| Shares Outstanding | 116,128,162 | 108,021,271 |
Flujo de Efectivo 9
| Métrica | Tendencia | Q1 2026 | Q4 2025 |
|---|---|---|---|
| Stock-based Comp | $2M | · | |
| Operating Cash Flow | $-7M | · | |
| CapEx | $6.0K | · | |
| Investing Cash Flow | $-6.0K | · | |
| Stock Issued | $8M | · | |
| Net Stock Activity | $8M | · | |
| Financing Cash Flow | $8M | · | |
| Net Change in Cash | $291.0K | · | |
| Free Cash Flow | $-7M | · |
Rentabilidad 2
| Métrica | Tendencia | Q1 2026 | Q4 2025 |
|---|---|---|---|
| ROA | -226.5% | · | |
| ROE | 360.3% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q1 2026 | Q4 2025 |
|---|---|---|---|
| Current Ratio | 1.4 | · | |
| Quick Ratio | 1.0 | · |
Valoración (TTM) 4
| Métrica | Tendencia | Q1 2026 | Q4 2025 |
|---|---|---|---|
| Market Cap | $99M | · | |
| P/B | -19.2 | · | |
| P / Cash Flow | -13.5 | · | |
| P / FCF | -13.5 | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Beneficio neto | $-29M | $-23M |
| EPS Diluido | $-0.30 | $-0.30 |
Balance general
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Ratio corriente | 1.1 | — |
| Ratio Rápido | 0.9 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Flujo de caja libre | $-20M | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.